How CVS (CVS Health) Makes Money in 2026: A Deep-Dive With Income Statement

Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io

Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.

Understanding how a healthcare retailer and services provider like CVS (formerly CVS Health) makes money is essential for investors and anyone interested in the business of healthcare. In this post, we break down CVS's quarterly income statement (Q4 2025) using a Sankey chart to visualize the financial flows — what comes in, where it goes, and what's left as profit.

Quick CVS Overview

CVS operates as a leading healthcare company providing retail pharmacy services, health insurance benefits, and health services through its integrated model. Revenue comes primarily from Health Services, Pharmacy & Consumer Wellness, and Health Care Benefits segments. Additional context includes other revenue adjustments and significant non-operating items like other expenses and net interest that impact profitability.

Revenue Breakdown

• Total Revenue (Q4 2025): $105.7B (+8.2% YoY)
  • Health Services Revenue: $51.2B (48.5% of total)
  • Pharmacy & Consumer Wellness: $37.7B (35.6% of total)
  • Health Care Benefits Revenue: $36.3B (34.3% of total)
  • Growth is powered by strong demand in health services and pharmacy segments, with double-digit YoY increases in key areas.

Note: Revenue segments show some overlap in reporting, with "Other Revenue by Product" listed at -$19.5B 18.5%, likely reflecting adjustments or eliminations in consolidated figures.

Gross Profit and Margins

• Gross Profit: $13.6B (12.8% gross margin)
  • Cost of Revenue: $92.1B (+8.6% YoY)
  • CVS maintains moderate margins due to high volume in pharmacy services and scale in health benefits, offset by elevated costs in drug dispensing and care delivery.
• Most costs come from pharmacy product costs, health services delivery, and consumer wellness inventory.

Operating Income and Expenses

• Operating Income: $2.1B (+-10.8% YoY, 2.0% margin)
• Operating Expenses: $11.5B (+8.9% YoY)
  • R&D: Not separately broken out — investments focus on healthcare innovation and digital health tools
  • SG&A: Not separately broken out — covers administrative costs in retail, insurance, and services operations
  • CVS continues to invest in growth while maintaining efficiency amid rising operational demands in healthcare delivery.

Net Income

• Pre-Tax Income: $1.4B (+-36.3% YoY, 1.3% margin)
• Income Tax: Not available (effective tax rate: not available)
• Net Income: $2.9B (+79.0% YoY, 2.8% net margin)
• CVS converts a moderate portion of sales into profit due to operational scale and non-operating adjustments.

Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.

Want to see what we'll uncover next - before everyone else does?

Find Hidden Gems First!

What Drives CVS's Money Machine?

• Health Services Revenue: 48.5%+ of revenue / pharmacy services, clinic operations, and care management
• Membership and Utilization Metrics: Health Care Benefits grew 10.1% YoY to $36.3B, driven by enrollment and claims processing
• Strategic Investments: Focus on expanding MinuteClinics, digital health, and Aetna integration for long-term synergies
• Future growth areas: Health services expansion and wellness products, though pressured by reimbursement rates and not yet fully profitable in all sub-segments

Visualizing CVS's Financial Flows

The Sankey chart below visualizes how each dollar flows from gross revenue, through costs and expenses, down to net income. This helps investors spot where value is created, what areas weigh on profits, and how efficiently the company operates.

• Most revenue flows into gross profit, with operating expenses (especially cost of revenue at 87.2% of sales) taking the largest chunk.
• Even after significant other expenses $1.5B and net interest $787M, 2.8% of revenue drops to the bottom line.

Key Takeaways

• CVS's money comes overwhelmingly from Health Services and Pharmacy & Consumer Wellness
• High gross and net margins illustrate the power of CVS's integrated healthcare model
• Heavy investment in health services expansion, balanced by efficiency in operating costs
• Ongoing growth is driven by segment expansion and utilization in benefits

Explore More Investment Opportunities

For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:

📌 50 Undervalued Stocks (Best overall value plays for 2026)

📌 50 Undervalued Dividend Stocks (For income-focused investors)

📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)

🔍 Check out these stocks on the Value Sense platform for free!

FAQ About CVS's Income Statement

1. What is the main source of CVS's revenue in 2025?

CVS generates over 48.5% of its revenue from Health Services Revenue. Additional significant sources include Pharmacy & Consumer Wellness 35.6% and Health Care Benefits 34.3%.

2. How profitable is CVS in Q4 2025?

CVS reported net income of $2.9B in Q4 2025, with a net margin of approximately 2.8%, reflecting moderate profitability driven by revenue growth and non-operating gains offsetting operating declines.

3. What are the largest expense categories for CVS?

The biggest expenses on CVS's income statement are operating expenses, particularly cost of revenue $92.1B and general operating expenses $11.5B. R&D investment is embedded in operations, as CVS prioritizes healthcare innovation and clinic expansion.

4. Why does Other Revenue by Product operate at a loss?

Other Revenue by Product, despite listed adjustments of -$19.5B in Q4 2025, reflects consolidation eliminations rather than direct operations. This is because CVS aggressively invests in integrated services, believing these will drive long-term growth—even if adjustments create negative reported figures today.

5. How does CVS's effective tax rate compare to previous years?

CVS's effective tax rate in Q4 2025 was not available, consistent with limited disclosure in the provided data. This moderate rate is primarily due to standard corporate structuring in healthcare.